BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 35956919)

  • 1. Insights into the Explicit Protective Activity of Herbals in Management of Neurodegenerative and Cerebrovascular Disorders.
    Behl T; Makkar R; Sehgal A; Sharma N; Singh S; Albratty M; Najmi A; Meraya AM; Bungau SG
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.
    Manoharan S; Guillemin GJ; Abiramasundari RS; Essa MM; Akbar M; Akbar MD
    Oxid Med Cell Longev; 2016; 2016():8590578. PubMed ID: 28116038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural Products from Plants and Algae for Treatment of Alzheimer's Disease: A Review.
    Klose J; Griehl C; Roßner S; Schilling S
    Biomolecules; 2022 May; 12(5):. PubMed ID: 35625622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders.
    Gupta R; Advani D; Yadav D; Ambasta RK; Kumar P
    Mol Neurobiol; 2023 Nov; 60(11):6476-6529. PubMed ID: 37458987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegenerative Diseases and Flavonoids: Special Reference to Kaempferol.
    Rahul ; Siddique YH
    CNS Neurol Disord Drug Targets; 2021; 20(4):327-342. PubMed ID: 33511932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Metabolic Basis for Nervous System Dysfunction in Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
    Maiese K
    Curr Neurovasc Res; 2023; 20(3):314-333. PubMed ID: 37488757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Products as the Potential to Improve Alzheimer's and Parkinson's Disease.
    Kim SW; Lee JH; Kim B; Yang G; Kim JU
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Autophagy in Neurodegenerative Diseases by Natural Products.
    Liu S; Li X
    Adv Exp Med Biol; 2020; 1207():725-730. PubMed ID: 32671789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential implications of polyphenolic compounds in neurodegenerative diseases.
    Shi R; Gao D; Stoika R; Liu K; Sik A; Jin M
    Crit Rev Food Sci Nutr; 2024; 64(16):5491-5514. PubMed ID: 36524397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases.
    Chen D; Zhang T; Lee TH
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-protein coupled receptors as therapeutic targets for neurodegenerative and cerebrovascular diseases.
    Guerram M; Zhang LY; Jiang ZZ
    Neurochem Int; 2016 Dec; 101():1-14. PubMed ID: 27620813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Bioenergy in Neurodegenerative Disease: Huntington and Parkinson.
    Tassone A; Meringolo M; Ponterio G; Bonsi P; Schirinzi T; Martella G
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.
    Fernández-Ruiz J; Romero J; Ramos JA
    Handb Exp Pharmacol; 2015; 231():233-59. PubMed ID: 26408163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Concise Review of Common Plant-derived Compounds as a Potential Therapy for Alzheimer's Disease and Parkinson's Disease: Insight into Structure-Activity-Relationship.
    Nishal S; Phaugat P; Bazaad J; Dhaka R; Khatkar S; Khatkar A; Khayatkashani M; Alizadeh P; Haghighi SM; Mehri M; Kashani HRK
    CNS Neurol Disord Drug Targets; 2023; 22(7):1057-1069. PubMed ID: 35702799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging, Neurodegenerative Disorders, and Cerebellum.
    Iskusnykh IY; Zakharova AA; Kryl'skii ED; Popova TN
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P-gp transporter and its role in neurodegenerative diseases.
    Rapposelli S; Digiacomo M; Balsamo A
    Curr Top Med Chem; 2009; 9(2):209-17. PubMed ID: 19200006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anhedonia in Neurodegenerative Diseases.
    Turner V; Husain M
    Curr Top Behav Neurosci; 2022; 58():255-277. PubMed ID: 35435648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection of Coenzyme Q10 in Neurodegenerative Diseases.
    Yang X; Zhang Y; Xu H; Luo X; Yu J; Liu J; Chang RC
    Curr Top Med Chem; 2016; 16(8):858-66. PubMed ID: 26311425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanomedicine for Neurodegenerative Disorders: Focus on Alzheimer's and Parkinson's Diseases.
    Jagaran K; Singh M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.